| P2093 | author name string | Aguzzi A | |
| | Glatzel M | |
| | Heppner FL | |
| | Montrasio F | |
| | Prinz M | |
| P2860 | cites work | Neuro-immune connection in spread of prions in the body? | Q57083714 |
| | The same prion strain causes vCJD and BSE | Q57092996 |
| | Turning off follicular dendritic cells | Q59068710 |
| | Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides | Q59691802 |
| | Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie | Q64447657 |
| | NGF modulates sympathetic innervation of lymphoid tissues | Q72037953 |
| | Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies | Q74452125 |
| | Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation | Q24525199 |
| | Branched polyamines cure prion-infected neuroblastoma cells | Q24529092 |
| | Impaired prion replication in spleens of mice lacking functional follicular dendritic cells | Q28144723 |
| | Mice devoid of PrP are resistant to scrapie | Q28249108 |
| | Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin | Q28507630 |
| | Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue | Q28586439 |
| | Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice | Q28587819 |
| | Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease | Q28588314 |
| | A route for prion neuroinvasion. | Q30328574 |
| | Immunoaffinity purification and neutralization of scrapie prion infectivity | Q33646402 |
| | Neuroinvasion by a Creutzfeldt-Jakob disease agent in the absence of B cells and follicular dendritic cells | Q33930758 |
| | Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody | Q33930771 |
| | Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease | Q33933969 |
| | Prions: health scare and biological challenge. | Q34185897 |
| | Doxycycline control of prion protein transgene expression modulates prion disease in mice | Q36527236 |
| | Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies | Q36663046 |
| | Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system | Q36688984 |
| | Sleepless in Bologna: transmission of fatal familial insomnia | Q41052801 |
| | Methods of sympathetic degeneration and alteration | Q41364932 |
| | Bovine spongiform encephalopathy and early onset variant Creutzfeldt-Jakob disease | Q41652295 |
| | Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs | Q42196937 |
| | Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state | Q42675291 |
| | Prion (PrPSc)-specific epitope defined by a monoclonal antibody | Q42816365 |
| | Between cows and monkeys | Q43213308 |
| | Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein | Q43522858 |
| | Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion | Q43702721 |
| | Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent | Q44592404 |
| | A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene | Q46098688 |
| | Antibodies inhibit prion propagation and clear cell cultures of prion infectivity | Q46161882 |
| | The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues | Q47713235 |
| | Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. | Q48263573 |
| | Prion research: the next frontiers | Q48540005 |
| | A crucial role for B cells in neuroinvasive scrapie. | Q48574532 |
| | Effectiveness of anthracycline against experimental prion disease in Syrian hamsters | Q48706421 |
| | Complement facilitates early prion pathogenesis | Q48930440 |
| | Normal host prion protein necessary for scrapie-induced neurotoxicity | Q49160879 |
| | Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. | Q54014234 |
| | Porphyrin and phthalocyanine antiscrapie compounds. | Q54061556 |
| | Potent inhibition of scrapie-associated PrP accumulation by congo red | Q54131452 |
| | Transepithelial prion transport by M cells | Q57083694 |
| | PrP expression in B lymphocytes is not required for prion neuroinvasion | Q57083708 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prion protein family | Q24724413 |
| P304 | page(s) | 745-749 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Nature Reviews Neuroscience | Q2108225 |
| P1476 | title | Interventional strategies against prion diseases | |
| P478 | volume | 2 | |